Legislation
The Government of Mauritius has introduced the Clinical Trials Act with the aim to provide the legal framework to conduct clinical trials. With the Clinical Trials Act adoption by the National Assembly on the 19 April 2011, Mauritius has seen a major development in its life sciences and research sector. The Act provides the legal framework for the conduct of clinical trials for the purpose of discovering or verifying the effects of investigational medicinal products. Clinical research conducted in Mauritius can provide solutions to a broad range of genetic, infectious and lifestyle diseases like diabetes, cardiovascular diseases, cancer, hypertension amongst others prevailing in Mauritius and countries of the region.
The Clinical Trials Act provides for the setting up of a:
- Clinical Research Regulatory Council (CRRC) - To regulate and control clinical trial licenses.
- Ethics Committee (EC) - To advise the CRRC regarding welfare, safety, health and protection of human subjects participating in clinical trials.
- PharmacoVigilance Committee (PVC) - To monitor all clinical trials being performed and ensure Good Clinical Practice (GCP).
